Healthcare AI 2025

CHINA Law and Practice Contributed by: Gil Zhang, Diana Li, Muran Sun and Yongqi Tao, Fangda Partners

Fangda Partners was founded in 1993 and is a leading full-service law firm with approximately 800 lawyers across offices in Beijing, Guangzhou, Hong Kong, Nanjing, Shanghai, Shenzhen and Singapore. The firm adopts a one-firm approach, providing in - tegrated legal services across all practice areas and locations. Recognised as the firm of choice for com - plex and high-stakes legal matters, Fangda advises major domestic and international companies on both transactions and disputes. Fangda’s team includes

lawyers qualified in the PRC, Hong Kong, the United States, the United Kingdom, Australia and Singapore, offering strong cross-border capabilities with a dis - tinct China focus. Fangda has extensive experience in AI and life sciences sectors, such as personalised medicine, digital health and biotechnology, including genomics and cancer diagnostics. The firm has as - sisted several leading pharmaceutical companies in deploying AI tools to support offline marketing and streamline business operations.

Authors

Gil Zhang is a partner at Fangda specialising in data protection, cybersecurity and AI regulatory compliance. He advises on various data protection matters, including contentious (eg, privacy litigation, law

Diana Li is a partner in Fangda’s life science team specialising in regulatory matters, licensing, mergers and acquisitions, private equity, foreign direct investment and general corporate matters. Diana is dedicated

enforcement, cybercrime-related criminal defence, data breach handling) and non-contentious matters and cross-border data transfer. He also provides AI regulatory advice to various AI clients and MNCs, including on AI market entry filing, regulatory compliance issues related to training data collection, fairness reviews, content moderation, AI outsourcing services and contracting and product liability issues, as well as other AI issues in and outside China. Gil is ranked as the leading data protection lawyer in China. technical questions and cutting-edge legal issues. With over a decade of experience in different technical standards and licensing models, her expertise lies in SEP-related disputes and licensing negotiations. Muran’s practice also covers competition law disputes. She has also successfully represented clients in licensing negotiations and other non-contentious IP matters. Muran Sun specialises in IP litigation and licensing, especially complex

to providing services to clients in the pharmaceutical and medical device sectors, among other healthcare industry clients including multinational companies, Chinese companies and investment funds. She is a member of the IBA Life Science Committee and has been recognised as an upcoming tier-4 lawyer by Chambers China, in the life science and healthcare practice sectors, for the past few years.

Yongqi Tao is a partner in Fangda’s dispute resolution team, specialising in commercial litigation and arbitration involving product quality, product liability, consumer protection and corporate governance disputes. He is

an experienced litigator who has represented major multinational companies and renowned Chinese companies from the automobile, electronics, retail, and manufacturing industries in a wide array of complex product liability and commercial litigation matters in major courts and arbitration institutes throughout the country.

38

CHAMBERS.COM

Powered by